Search research articles
Contact Us
Filters
Showing results (81-90 of 257) with videos related to
Page
of 26
Sort By:
BJU International
|
March 17, 2010
Carbonic anhydrase IX and pathological features as predictors of outcome in patients with metastatic clear-cell renal cell carcinoma receiving vascular endothelial growth factor-targeted therapy
Toni K Choueiri, Meredith M Regan, Jonathan E Rosenberg, et al.
Cancer Research
|
April 19, 2005
Arginase-producing myeloid suppressor cells in renal cell carcinoma patients: a mechanism of tumor evasion
Arnold H Zea, Paulo C Rodriguez, Michael B Atkins, et al.
Developmental Cell
|
August 5, 2014
D-cyclins repress apoptosis in hematopoietic cells by controlling death receptor Fas and its ligand FasL
Yoon Jong Choi, Borja Saez, Lars Anders, et al.
European Journal of Cancer (Oxford, England : 1990)
|
May 31, 2022
Impact of MET status on treatment outcomes in papillary renal cell carcinoma: A pooled analysis of historical data
Laurence Albiges, Daniel Y C Heng, Jae Lyun Lee, et al.
Clinical Genitourinary Cancer
|
October 1, 2015
Tumor Vascularity in Renal Masses: Correlation of Arterial Spin-Labeled and Dynamic Contrast-Enhanced Magnetic Resonance Imaging Assessments
Yue Zhang, Payal Kapur, Qing Yuan, et al.
BMC Cancer
|
October 27, 2023
Regulation of HHLA2 expression in kidney cancer and myeloid cells
Tomonari Shigemura, Nahuel Perrot, Zimo Huang, et al.
Cancer Immunology Research
|
November 8, 2015
PD-L1 Antibodies to Its Cytoplasmic Domain Most Clearly Delineate Cell Membranes in Immunohistochemical Staining of Tumor Cells
Kathleen M Mahoney, Heather Sun, Xiaoyun Liao, et al.
Cancer
|
June 11, 2015
Phase 2 trial of sunitinib and gemcitabine in patients with sarcomatoid and/or poor-risk metastatic renal cell carcinoma
M Dror Michaelson, Rana R McKay, Lillian Werner, et al.
EMBO Molecular Medicine
|
February 6, 2014
A novel direct activator of AMPK inhibits prostate cancer growth by blocking lipogenesis
Giorgia Zadra, Cornelia Photopoulos, Svitlana Tyekucheva, et al.
Radiology
|
May 29, 2009
Does arterial spin-labeling MR imaging-measured tumor perfusion correlate with renal cell cancer response to antiangiogenic therapy in a mouse model?
Rachel Schor-Bardach, David C Alsop, Ivan Pedrosa, et al.
Page
of 26
Search research articles
Search
Showing results (81-90 of 257) with videos related to
Sort By:
Page
of 26
BJU International
|
March 17, 2010
Carbonic anhydrase IX and pathological features as predictors of outcome in patients with metastatic clear-cell renal cell carcinoma receiving vascular endothelial growth factor-targeted therapy
Toni K Choueiri, Meredith M Regan, Jonathan E Rosenberg, et al.
Cancer Research
|
April 19, 2005
Arginase-producing myeloid suppressor cells in renal cell carcinoma patients: a mechanism of tumor evasion
Arnold H Zea, Paulo C Rodriguez, Michael B Atkins, et al.
Developmental Cell
|
August 5, 2014
D-cyclins repress apoptosis in hematopoietic cells by controlling death receptor Fas and its ligand FasL
Yoon Jong Choi, Borja Saez, Lars Anders, et al.
European Journal of Cancer (Oxford, England : 1990)
|
May 31, 2022
Impact of MET status on treatment outcomes in papillary renal cell carcinoma: A pooled analysis of historical data
Laurence Albiges, Daniel Y C Heng, Jae Lyun Lee, et al.
Clinical Genitourinary Cancer
|
October 1, 2015
Tumor Vascularity in Renal Masses: Correlation of Arterial Spin-Labeled and Dynamic Contrast-Enhanced Magnetic Resonance Imaging Assessments
Yue Zhang, Payal Kapur, Qing Yuan, et al.
BMC Cancer
|
October 27, 2023
Regulation of HHLA2 expression in kidney cancer and myeloid cells
Tomonari Shigemura, Nahuel Perrot, Zimo Huang, et al.
Cancer Immunology Research
|
November 8, 2015
PD-L1 Antibodies to Its Cytoplasmic Domain Most Clearly Delineate Cell Membranes in Immunohistochemical Staining of Tumor Cells
Kathleen M Mahoney, Heather Sun, Xiaoyun Liao, et al.
Cancer
|
June 11, 2015
Phase 2 trial of sunitinib and gemcitabine in patients with sarcomatoid and/or poor-risk metastatic renal cell carcinoma
M Dror Michaelson, Rana R McKay, Lillian Werner, et al.
EMBO Molecular Medicine
|
February 6, 2014
A novel direct activator of AMPK inhibits prostate cancer growth by blocking lipogenesis
Giorgia Zadra, Cornelia Photopoulos, Svitlana Tyekucheva, et al.
Radiology
|
May 29, 2009
Does arterial spin-labeling MR imaging-measured tumor perfusion correlate with renal cell cancer response to antiangiogenic therapy in a mouse model?
Rachel Schor-Bardach, David C Alsop, Ivan Pedrosa, et al.
Page
of 26